ANIP

ANI Pharmaceuticals, Inc.
Data: 2026-11-12
Analyzing positioning… Options positioning — based on yesterday's biggest open-interest changes See the chart Institutional flows
Track record
signal day → next-day price move
Quick Stats
Nov 12, 2026

50.8

AI Score

BUY

0.33

Volume Ratio

TBA

Next Earnings

15

+ve Days (30d)

15

-ve Days (30d)

ANIP Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

ANIP Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

ANIP Options - Sort by Max open Interest (near term)

12th November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ANIP Daily Out of Money Options - Sort by Max open Interest (near term)

12th November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ANIP Daily In the Money Options - Sort by Max open Interest (near term)

12th November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ANIP Most Active Options by Volume(near term)

12th November 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track
ANIP Technical Chart Pro Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select an indicator above — it will be added as a pane under the price chart with aligned dates.

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ANIP Stock Summary

Last updated Nov 12, 2026

ANIP is currently trading at $71.72, positioned below its 200-day moving average of $77.06, suggesting bearish momentum. The stock has a 52-week range of $67.135 to $89.57.

Technical Analysis: The 50-day moving average stands at $72.33, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 49.29, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.199, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ANIP at 50.8/100 with a BUY recommendation.

ANIP (ANI Pharmaceuticals, Inc.) Indicators

Last updated Nov 12, 2026

Indicator Value
RSI(14) 49.29
CMF (20) -0.199
ROC (10) -2.447
ADX (14) 12.151
Indicator Value
MACD (12,26,9) -0.709
AROONOSC (14) -7.143
WILLAMS %R (14) -52.228
MFI (14) 50.702

ANIP Candlestick Patterns

No validated candlestick patterns fired for ANIP in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.

ANI Pharmaceuticals, Inc. is below both the 50 Day and 200 Day SMA which is considered Bearish.

ANIP Moving Averages Analysis

ANIP (ANI Pharmaceuticals, Inc.) Simple Moving Averages

Moving Averages are last updated Nov 12, 2026

Days MA
10 70.49
20 71.48
30 71.69
50 72.33
100 75.69
200 77.06

ANIP Fundamental Analysis

P/E (Forward) 6.7295
P/E (Trailing) 14.165
Market Cap ($) 1.6 billion
Earnings/Share ($) 5.03
Net Profit Margin (%) 0.1122
Dividend/Share ($) --
EPS Estimate Current Year ($) 9.5087
EPS Estimate Next Year ($) 10.2031
WallStreet Target Price ($) 105.22
Most Recent Quarter

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.